Jupiter Neurosciences Strengthens Board with Appointment of Dr. Tomas J. Philipson
Former White House Council of Economic Advisors Brings Extensive Government, Academic, and Private Sector Experience to Advance Company's Strategic Growth...
Neuroscience
Active Motif Announces Exclusive Global Distribution Agreement with Arima Genomics for Advanced 3D Genomics Solutions
Agreement expands Active Motif's research genomics portfolio while supporting Arima's strategic focus on its clinical diagnostics platform CARLSBAD, Calif., July...
Cumulus Neuroscience and Muse by Interaxon Bring Validated At-Home Sleep EEG to CNS Clinical Trials
Collaboration adds brain-based sleep measurement to the NeuLogiq® multi-modal platformBELFAST, Northern Ireland, DUBLIN and TORONTO, July 6, 2026 /PRNewswire/ -- Cumulus...
Neurophet Supplies ‘Neurophet AQUA’ to Raffles Medical in Singapore
Providing Neurophet AQUA capable of analyzing brain atrophy and white matter degeneration… Securing meaningful clinical referenceSEOUL, South Korea, July 2,...
Novartis receives European Commission approval for Itvisma® for spinal muscular atrophy (SMA)
First gene replacement therapy in the EU for broad population with SMA, including children two years and older, teens and...
Remepy Publishes New Evidence Showing its Hybrid Drug, Hybridopa™, Effect on Structural Connectivity in the Brain of Parkinson’s Patients Associated with Improved Clinical Outcome
New npj Parkinson's Disease publication, building on the previously reported Hybridopa™ Phase IIa results, demonstrates for the first time, that...
Magnetic Resonance Imaging (MRI) Market to Reach USD 10.2 Billion by 2036 as AI Reconstruction and Low-Helium Systems Improve Imaging Efficiency | FMI
NEWARK, Del., June 30, 2026 /PRNewswire/ -- The global Magnetic Resonance Imaging (MRI) Market, according to Future Market Insights, is...
FHIMA Celebrates 50th Annual Convention with “Reach for the Stars” Theme, Nationally Recognized Keynote Speakers, and Interactive Healthcare Innovations
Florida's premier health information management conference welcomes hundreds of healthcare professionals to Orlando, July 12–15, 2026.ORLANDO, Fla., June 30, 2026...
How Advocacy Perspectives Can Improve Neurology Research, Upcoming Webinar Hosted by Xtalks
In this free webinar brought to you by Xtalks Life Sciences United (XLSU), see how advocacy perspectives can help shape...
Allucent Launches IGNITE™ Site Network to Enhance Speed, Quality, and Predictability Across Clinical Trial Delivery
Pre-qualified global site network aligned to Allucent's therapeutic Centers of Expertise (ACEs)Defined execution commitments for feasibility, startup, and enrollmentBuilt on...
Taysha Gene Therapies Announces Multiple Presentations Highlighting its TSHA-102 Clinical Program at the 2026 IRSF Rett Syndrome Scientific Meeting
Recently disclosed longer-term REVEAL Part A data demonstrated broad, multi-domain functional impact that deepened over time through ≥12 months post-TSHA-102...
Shore Medical Center First in New Jersey to offer the VELYS™ Active Robotic Assistance Technology for Spinal Procedures
Next generation, dual-use robotics and navigation platform allows for surgical guidance tailored to surgeon preference and the patient SOMERS POINT,...
A Brain Recovery Center Finally Has a Website as Powerful as Its Therapy
A Platform Built for Clarity and ConnectionNEW YORK, June 24, 2026 /PRNewswire/ -- Digital Silk led the engagement from strategy...
Petauri Named to MM+M Agency 100 2026
Rapidly growing pharmaceutical services platform receives industry recognition NASHVILLE, Tenn., June 24, 2026 /PRNewswire/ -- Petauri, a purpose-built pharmaceutical services platform,...
Precision Neurology Made Practical: Faster Development Through Biomarkers and Real-World Insight, Upcoming Webinar Hosted by Xtalks
In this free webinar, gain insight into how patient identification approaches can improve study efficiency in precision neurology programs. Attendees...
Teva Releases Q2 2026 Aide Memoire
TEL AVIV, Israel, June 18, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that...
Teva Submits NDA for Ecopipam, a First-in-Class Investigational Therapy for Pediatric Tourette Syndrome
NDA submission supported by positive Phase 3 data recently published in JAMA Neurology.Ecopipam is a first-in-class selective dopamine D1 receptor...
Teva to Host Conference Call to Discuss Second Quarter 2026 Financial Results on July 29, 2026 at 8 a.m. ET
TEL AVIV, Israel and PARSIPPANY, N.J., June 18, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA)...
10x Genomics and Cleveland Clinic Collaborate to Advance Research in Diagnostic Applications of Single Cell and Spatial Technologies in Patients with Bladder Cancer
Collaboration aims to identify biomarkers predictive of antibody-drug conjugate (ADC) treatment response using 10x's single cell and spatial platformsPLEASANTON, Calif.,...
10x Genomics and Cleveland Clinic Collaborate to Advance Research in Diagnostic Applications of Single Cell and Spatial Technologies in Patients with Bladder Cancer
Collaboration aims to identify biomarkers predictive of antibody-drug conjugate (ADC) treatment response using 10x's single cell and spatial platformsPLEASANTON, Calif.,...